Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)

Clinical trial NCT06080256 · UNKNOWN

Trial details

NCT number: NCT06080256
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Intracranial Atherosclerosis Atherosclerotic Plaque Stenosis

Start date: 2023-12-30
Primary completion: 2024-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.